High risk of mumps infection in children who received one dose of mumps-containing vaccine: waning immunity to mumps in children aged 2-5 years from kindergartens in Jiangsu Province, China

References

• Hviid A, Rubin S, Muhlemann K. Mumps. Lancet (London, England). 2008;371:932–44. doi:10.1016/S0140-6736(08)60419-5.
   PubMed Web of Science ®Google Scholar
• Liu Y, Hu Y, Deng X, Wang Z, Lu P, Ma F, Zhou M, Liu P, Min J. Seroepidemiology of mumps in the general population of Jiangsu province, China after introduction of a one-dose measles-mumps-rubella vaccine. Sci Rep. 2015;5:14660. doi:10.1038/srep14660.
   PubMed Web of Science ®Google Scholar
• Su QR, Liu J, Ma C, Fan CX, Wen N, Luo HM, Wang HQ, Li L, Hao LX. Epidemic profile of mumps in China during 2004–2013. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 2016;50:611–14. doi:10.3760/cma.j.issn.0253-9624.2016.07.009.
   PubMedGoogle Scholar
• Chen CC, Lu CC, Su BH, Chen KT. Epidemiologic features of mumps in Taiwan from 2006 to 2011: a new challenge for public health policy. World J Pediatr. 2015;11:141–47. doi:10.1007/s12519-014-0525-6.
   PubMed Web of Science ®Google Scholar
• Eriksen J, Davidkin I, Kafatos G, Andrews N, Barbara C, Cohen D, DUKS A, Griskevicius A, Johansen K, Bartha K, et al. Seroepidemiology of mumps in Europe (1996–2008): why do outbreaks occur in highly vaccinated populations? Epidemiol Infect. 2013;141:651–66. doi:10.1017/S0950268812001136.
   PubMed Web of Science ®Google Scholar
• Karcheva M, Gancheva G. Seroprevalence of IgG antibodies against mumps in bulgarian children under 18 years of age. Balkan Med J. 2013;30:16–18. doi:10.5152/balkanmedj.
   PubMed Web of Science ®Google Scholar
• Smits G, Mollema L, Hahne S, de Melker H, Tcherniaeva I, Waaijenborg S, van Binnendijk R, van der Klis F, Berbers G. Seroprevalence of mumps in The Netherlands: dynamics over a decade with high vaccination coverage and recent outbreaks. PLoS One. 2013;8:e58234. doi:10.1371/journal.pone.0058234.
   PubMed Web of Science ®Google Scholar
• Marin M, Quinlisk P, Shimabukuro T, Sawhney C, Brown C, Lebaron CW. Mumps vaccination coverage and vaccine effectiveness in a large outbreak among college students–iowa, 2006. Vaccine. 2008;26:3601–07. doi:10.1016/j.vaccine.2008.04.075.
   PubMed Web of Science ®Google Scholar
• Anderson RM, May RM. Vaccination and herd immunity to infectious diseases. Nature. 1985;318:323–29. doi:10.1038/318323a0.
   PubMed Web of Science ®Google Scholar
• Muhsen K, Shohat T, Aboudy Y, Mendelson E, Algor N, Anis E, Cohen D. Sero-prevalence of mumps antibodies in subpopulations subsequently affected by a large scale mumps epidemic in Israel. Vaccine. 2011;29:3878–82. doi:10.1016/j.vaccine.2011.03.047.
   PubMed Web of Science ®Google Scholar
• Lewnard JA, Grad YH. Vaccine waning and mumps re-emergence in the United States. Sci Transl Med. 2018;10:eaao5945.
   PubMed Web of Science ®Google Scholar
• WHO. The immunological basis for immunization series mumps. 2010. [accessed 2012 Sep 9]. http://www.who.int/wer/2007/wer8207.pdf?ua=1.
   Google Scholar
• Levine DA. Vaccine-preventable diseases in pediatric patients: a review of measles, mumps, rubella, and varicella. Pediatr Emerg Med Pract. 2016;13:1–20.
   PubMedGoogle Scholar
• Carazo Perez S, De Serres G, Bureau A, Skowronski DM. Reduced antibody response to infant measles vaccination: effects based on type and timing of the first vaccine dose persist after the second dose. Clin Infect Dis. 2017;65:1094–102. doi:10.1093/cid/cix510.
   PubMed Web of Science ®Google Scholar
• Gouma S, Sane J, Gijselaar D, Cremer J, Hahne S, Koopmans M, van Binnendijk R. Two major mumps genotype G variants dominated recent mumps outbreaks in the Netherlands (2009–2012). J Gen Virol. 2014;95:1074–82. doi:10.1099/vir.0.062943-0.
   PubMed Web of Science ®Google Scholar
• Woudenberg T, van der Maas NAT, Knol MJ, de Melker H, van Binnendijk RS, Hahne SJM. Effectiveness of early measles, mumps, and rubella vaccination among 6–14-month-old infants during an epidemic in the Netherlands: an observational cohort study. J Infect Dis. 2017;215:1181–87. doi:10.1093/infdis/jiw586.
   PubMed Web of Science ®Google Scholar
• Diaz Ortega JL, Castaneda D, Arellano Quintanilla DM, Martinez D, Trumbo SP, Fernandez de Castro J. Antibody persistence in children aged 6–7years one year following booster immunization with two MMR vaccines applied by aerosol or by injection. Vaccine. 2017;35:3116–22. doi:10.1016/j.vaccine.2017.04.027.
   PubMed Web of Science ®Google Scholar
• Kenny L, O’Kelly E, Connell J, De Gascun C, Hassan J. Mumps outbreaks in a highly vaccinated population: investigation of a neutralization titre against the current circulating wildtype genotype G5 mumps virus. J Clin Virol. 2016;74:8–12. doi:10.1016/j.jcv.2015.11.023.
   PubMed Web of Science ®Google Scholar
• Leuridan E, Maertens K, Wautier M, Hutse V, Theeten H. Susceptibility to measles, mumps, and rubella in 5-year-old children in Flanders, Belgium. Eur J Pediatr. 2015;174:925–32. doi:10.1007/s00431-014-2481-5.
   PubMed Web of Science ®Google Scholar
• Patel LN, Arciuolo RJ, Fu J, Giancotti FR, Zucker JR, Rakeman JL, Rosen JB. Mumps outbreak among a highly vaccinated university community-New York City, January-April 2014. Clin Infect Dis. 2017;64:408–12. doi:10.1093/cid/ciw762.
   PubMed Web of Science ®Google Scholar
• Wang H, Hu Y, Zhang G, Zheng J, Li L, An Z. Meta-analysis of vaccine effectiveness of mumps-containing vaccine under different immunization strategies in China. Vaccine. 2014;32:4806–12. doi:10.1016/j.vaccine.2014.05.061.
   PubMed Web of Science ®Google Scholar
• Date AA, Kyaw MH, Rue AM, Klahn J, Obrecht L, Krohn T, Rowland J, Rubin S, Safranek T, Bellini W, et al. Long-term persistence of mumps antibody after receipt of 2 measles-mumps-rubella (MMR) vaccinations and antibody response after a third MMR vaccination among a university population. J Infect Dis. 2008;197:1662–68. doi:10.1086/590464.
   PubMed Web of Science ®Google Scholar
• Davidkin I, Jokinen S, Broman M, Leinikki P, Peltola H. Persistence of measles, mumps, and rubella antibodies in an MMR-vaccinated cohort: a 20-year follow-up. J Infect Dis. 2008;197:950–56. doi:10.1086/588418.
   PubMed Web of Science ®Google Scholar
• Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, Brown D, Ramsay ME. Vaccine effectiveness estimates, 2004–2005 mumps outbreak, England. Emerg Infect Dis. 2007;13:12–17. doi:10.3201/eid1301.060649.
   PubMed Web of Science ®Google Scholar
• Cortese MM, Jordan HT, Curns AT, Quinlan PA, Ens KA, Denning PM, Dayan G. Mumps vaccine performance among university students during a mumps outbreak. Clin Infect Dis. 2008;46:1172–80. doi:10.1086/588450.
   PubMed Web of Science ®Google Scholar
• Vandermeulen C, Clement F, Roelants M, Van Damme P, Hoppenbrouwers K, Leroux-Roels G. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination. J Infect Dis. 2009;199:1457–60. doi:10.1086/598482.
   PubMed Web of Science ®Google Scholar
• Gu XX, Plotkin SA, Edwards KM, Sette A, Mills KHG, Levy O, Sant AJ, Mo A, Alexander W, Lu KT, et al. waning immunity and microbial vaccines-workshop of the national institute of allergy and infectious diseases. Clin Vaccine Immunol. 2017;24:e00034–17.
   PubMedGoogle Scholar